David W. Dodick, MD

home / authors / david-w-dodick-md

Director, Concussion and Headache Programs, Mayo Clinic; Chair, American Brain Foundation, IHS-Global Patient Advocacy Coalition

Articles

Therapies in Development for Acute Migraine

Therapies in Development for Acute Migraine

Robert Cowan, MD;David W. Dodick, MD
October 30th 2020
Ubrogepant: Treatment for Acute Migraine

Ubrogepant: Treatment for Acute Migraine

Robert Cowan, MD;David W. Dodick, MD
October 30th 2020
Rimegepant: Treatment for Acute Migraine

Rimegepant: Treatment for Acute Migraine

Robert Cowan, MD;David W. Dodick, MD
October 30th 2020
Patient Selection for Acute Migraine Therapy

Patient Selection for Acute Migraine Therapy

Robert Cowan, MD;David W. Dodick, MD
October 30th 2020
Acute Migraine Treatment Goals

Acute Migraine Treatment Goals

Robert Cowan, MD;David W. Dodick, MD
October 30th 2020
Treatment Goals for Acute Migraine

Treatment Goals for Acute Migraine

Robert Cowan, MD;David W. Dodick, MD
October 30th 2020
Treating Acute Migraine in the Community Setting

Treating Acute Migraine in the Community Setting

Robert Cowan, MD;David W. Dodick, MD
October 30th 2020
Acute Migraine Treatment: What’s Next?

Acute Migraine Treatment: What’s Next?

Robert Cowan, MD;David W. Dodick, MD
October 30th 2020
Real-World Experience With Gepants for Acute Migraine

Real-World Experience With Gepants for Acute Migraine

Robert Cowan, MD;David W. Dodick, MD
October 30th 2020
Gepants for Acute Migraine: Patient Management

Gepants for Acute Migraine: Patient Management

Robert Cowan, MD;David W. Dodick, MD
October 30th 2020
Gepants for Acute Migraine: Safety & Efficacy Data

Gepants for Acute Migraine: Safety & Efficacy Data

Robert Cowan, MD;David W. Dodick, MD
October 30th 2020
Advances in the Treatment of Acute Migraine

Advances in the Treatment of Acute Migraine

Robert Cowan, MD;David W. Dodick, MD
October 30th 2020
Burden of Migraine

Burden of Migraine

Robert Cowan, MD;David W. Dodick, MD
October 30th 2020
Site Logo

Migraine Rx in the ED: A Systematic Review

Thomas P. Bravo, MD;David W. Dodick, MD
September 2nd 2014

Here: highlights from a systematic review that these authors view as a substantial step forward in establishing an evidence-based approach to migraine treatment in the acute care setting.

Latest Updated Articles

Kelsey E. Poisson, MD (Credit: Nationwide Children’s)
Published: November 27th 2024 | Updated: December 11th 2024
Race, Socioeconomic Status Play Major Role in Disparities Seen in Pediatric NMOSD Outcomes
Robert A. Hauser, MD, MBA (Credit: USF Health)
Published: October 17th 2024 | Updated: October 21st 2024
FDA Approves AbbVie’s 24-Hour Foscarbidopa/Foslevodopa Pump for Advanced Parkinson Disease Treatment
Jacob McCauley, PhD (Credit: Miami Miller School of Medicine)
Published: September 18th 2024 | Updated: September 20th 2024
Multi-Ethnic Study Identifies Ancestry-Specific Genetic Variants that Influence Risk of Multiple Sclerosis
Todd Sherer, PhD (Credit: The Michael J. Fox Foundation for Parkinson's Research)
Published: September 9th 2024 | Updated: September 11th 2024
FDA Supports Alpha-Synuclein Seed Amplification Assay Biomarker for Clinical Trials in Parkinson Disease
Lee Golden, MD (Credit: PTC Therapeutics)
Published: August 24th 2024 | Updated: August 26th 2024
Vatiquinone Pharmacokinetics Influenced by CYP3A4 Inhibitors and Inducers in Phase 1 Study
Renaud Du Pasquier, MD (Credit: University of Lausanne)
Published: August 22nd 2024 | Updated: August 23rd 2024
Novel Cell-Based Assay Enhances Detection of Autoantibodies in Neurological Disorders
© 2024 MJH Life Sciences

All rights reserved.